Product Image

SLIMit

Health Direct
3.9
★ ★ ★ ★ ★
(590 ratings)
Chromium 400 mcg
Resveratrol 10 mg
Product Image
Score41
High-dose chromium provides some metabolic relevance, but the main blend is hidden and resveratrol is lightly dosed. Limited disclosure and weak value make it a poor weight-management choice.
How scoring works
Quantity:56 Capsule(s) • (28 servings)
Goals:
Metabolism Boost

Score 41

High-dose chromium provides some metabolic relevance, but the main blend is hidden and resveratrol is lightly dosed. Limited disclosure and weak value make it a poor weight-management choice.
How scoring works
$39.99($1.42 per serving)
iHerb
$ 39.99
Amazon
$ 39.99
Report prices

Analysis

Chromium chloride is supplied at 400 mcg, but it is a less compelling form than common organic chromium complexes. The dose may support glucose metabolism, yet that does not establish meaningful weight loss by itself.

Trans-resveratrol is clearly identified from Polygonum cuspidatum, though 10 mg is a small amount and the capsule offers no stated absorption support. The 810 mg proprietary blend is the dominant part of the formula, but its ingredients and individual doses are unavailable.

The formula is therefore difficult to assess for appetite, thermogenesis, or sustained metabolic support. Its costly serving further weakens the case for choosing it over a transparent, goal-specific product.

Who is it for
  • Adults specifically seeking chromium-based metabolic support
  • Users whose clinician has reviewed the high chromium amount
  • People comfortable with a proprietary formula
Best for
  • Chromium supplementation
  • Limited carbohydrate-metabolism support
  • Short trial use with glucose monitoring when appropriate

Pros

  • Clearly discloses 400 mcg chromium
  • Identifies the trans form of resveratrol
  • Uses a simple capsule format

Cons

  • The main 810 mg blend is fully proprietary
  • Chromium chloride is a less compelling form
  • Resveratrol is limited to 10 mg
  • Serving value is weak

Warnings

  • Chromium may add to the glucose-lowering effects of insulin or diabetes medicines, increasing the chance of low blood sugar.
  • Polygonum-derived resveratrol may retain emodin when removal is not verified, which can cause loose stools or cramping.
  • The proprietary blend prevents a full interaction and tolerance review because its ingredients are not disclosed.

Nutrient quality

40 Lower impact

Trans-resveratrol is identified, while chromium chloride has weak absorption and the larger blend has no form detail, and chromium is substantial, but 10 mg resveratrol is minimal and the proprietary blend cannot be judged. The chromium amount is high for general use, while hidden blend contents prevent a complete safety assessment, while chromium and resveratrol have limited weight-management relevance, while the hidden blend prevents a strong fit assessment.

.

Ingredient transparency

41 Lower impact

Several core ingredients have amounts, but a proprietary blend hides important component doses, and a proprietary blend hides the amounts of its individual components. Serving count is supplied, but complete daily-use directions are not provided, while inactive ingredients and excipients are not included in the supplied label details.

.

Customer satisfaction

60 Moderate impact

The supplied average rating is weak, and moderate review volume provides a reasonable evidence base. Specific review themes are unavailable, so repeated negatives and real-world fit remain uncertain.

.

Value for money

27 Situational impact

Major dose or disclosure problems make the formula difficult to justify on quality alone, and the very high serving cost substantially weakens value. The proprietary blend prevents assessment of low-value additions, while dose, disclosure, or serving-value limitations make it less competitive than similar products.

.
Report analysis

Goals

Metabolism Boost
Impact
Moderate effect
C+ Goal FitD+ Strength of SupportC- CoverageF Formula Quality
Resveratrol · 10 mg

Chromium can support insulin action and carbohydrate metabolism, but most of the formula is hidden in a proprietary blend. The small resveratrol amount is unlikely to add meaningful mitochondrial support.

Breadth appears wide on the label, yet undisclosed ingredient amounts prevent a reliable potency assessment. Chromium chloride is a less compelling form than better-studied organic chromium complexes.

Study evidence
Chromium Supportive 47 studies
Resveratrol Supportive 21 studies

Ingredients

IngredientAmount per serving
Chromium (Chromium Chloride)
400 mcg
Proprietary Blend
810 mg
Trans-Resveratrol (Polygonum cuspidatum (root) extract)
10 mg
N-Hance Complex
24 mg
Gluten Free Adults 18–50 Dairy Free
Report overview
F Active Ingredient Quality & BioavailabilityA- Dose, Safety & Label TransparencyD- Value

The chromium dose is substantial, but chromium chloride has poor absorption compared with organic forms. No trademarked chromium source is identified, and the label gives only one amount for the compound. The normalized cost is relatively high despite the formula containing additional blends.

C Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value

The trans isomer is explicitly disclosed, but its daily amount is too small to align well with the collection goal. A standard capsule provides no absorption enhancement, and the larger proprietary blend does not clarify resveratrol extract yield or purity. Polygonum cuspidatum root extract lacks emodin-removal verification, which may create mild laxative effects, while the low active amount also makes value poor.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis.
    Hu X; Wang W; Su X; Peng H; Tan Z; Li Y; Huang Y · PeerJ · 2023
    Meta-analysis2,362 participants41 studies pooledMetabolism Boost forChromium
  2. Systematic review and meta-analysis of the efficacy and safety of chromium supplementation in diabetes.
    Suksomboon N; Poolsup N; Yuwanakorn A · Journal of clinical pharmacy and therapeutics · 2015
    Meta-analysis25 studies pooledMetabolism Boost forChromium
  3. [Chromium supplementation in patients with type 2 diabetes and high risk of type 2 diabetes: a meta-analysis of randomized controlled trials].
    San Mauro-Martin I; Ruiz-León AM; Camina-Martín MA; Garicano-Vilar E; Collado-Yurrita L; Mateo-Silleras Bd; Redondo Del Río Mde P · Nutricion hospitalaria · 2017
    Meta-analysis13 studies pooledMetabolism Boost forChromium
  4. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes.
    Anderson RA; Cheng N; Bryden NA; Polansky MM; Cheng N; Chi J; Feng J · Diabetes · 1997
    Randomized trial180 participantsMetabolism Boost forChromium
  5. The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease.
    Farrokhian A; Mahmoodian M; Bahmani F; Amirani E; Shafabakhsh R; Asemi Z · Biological trace element research · 2021
    Randomized trial64 participantsWeight Loss forChromium
  6. Chromium picolinate supplementation attenuates body weight gain and increases insulin sensitivity in subjects with type 2 diabetes.
    Martin J; Wang ZQ; Zhang XH; Wachtel D; Volaufova J; Matthews DE; Cefalu WT · Diabetes care · 2006
    Randomized trial37 participantsMetabolism Boost Weight Loss forChromium
  7. Chromium picolinate reduces insulin resistance in polycystic ovary syndrome: Randomized controlled trial.
    Ashoush S; Abou-Gamrah A; Bayoumy H; Othman N · The journal of obstetrics and gynaecology research · 2017
    Randomized trial100 participantsWeight Loss forChromium
  8. The Effects of Supplementation with Chromium on Insulin Resistance Indices in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Heshmati J; Omani-Samani R; Vesali S; Maroufizadeh S; Rezaeinejad M; Razavi M; Sepidarkish M · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2018
    Meta-analysis268 participants5 studies pooledMetabolism Boost forChromium
  9. Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.
    Kooshki F; Moradi F; Karimi A; Niazkar HR; Khoshbaten M; Maleki V; Pourghassem Gargari B · European journal of gastroenterology & hepatology · 2021
    Randomized trial46 participantsWeight Loss forChromium
  10. Improved meta-analytic methods show no effect of chromium supplements on fasting glucose.
    Bailey CH · Biological trace element research · 2014
    Meta-analysis809 participants16 studies pooledMetabolism Boost forChromium
  11. A pilot study of chromium picolinate for weight loss.
    Yazaki Y; Faridi Z; Ma Y; Ali A; Northrup V; Njike VY; Liberti L; Katz DL · Journal of alternative and complementary medicine (New York, N.Y.) · 2010
    Randomized trial80 participantsWeight Loss forChromium
  12. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status.
    Lukaski HC; Siders WA; Penland JG · Nutrition (Burbank, Los Angeles County, Calif.) · 2007
    Randomized trial83 participantsWeight Loss forChromium
  13. Chromium effects on glucose tolerance and insulin sensitivity in persons at risk for diabetes mellitus.
    Ali A; Ma Y; Reynolds J; Wise JP; Inzucchi SE; Katz DL · Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2011
    Randomized trial59 participantsMetabolism Boost forChromium
  14. Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults.
    Iqbal N; Cardillo S; Volger S; Bloedon LT; Anderson RA; Boston R; Szapary PO · Metabolic syndrome and related disorders · 2009
    Randomized trial63 participantsMetabolism Boost Weight Loss forChromium
  15. Effect of chromium supplementation on the glucose homeostasis and anthropometry of type 2 diabetic patients: Double blind, randomized clinical trial: Chromium, glucose homeostasis and anthropometry.
    Guimarães MM; Carvalho AC; Silva MS · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2017
    Randomized trial56 participantsWeight Loss forChromium
  16. Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial.
    Kleefstra N; Houweling ST; Jansman FG; Groenier KH; Gans RO; Meyboom-de Jong B; Bakker SJ; Bilo HJ · Diabetes care · 2006
    Randomized trial46 participantsWeight Loss forChromium
  17. Chromium supplementation in non-obese non-diabetic subjects is associated with a decline in insulin sensitivity.
    Masharani U; Gjerde C; McCoy S; Maddux BA; Hessler D; Goldfine ID; Youngren JF · BMC endocrine disorders · 2013
    Randomized trial31 participantsMetabolism Boost forChromium
  18. Association Between Essential and Non-essential Metals, Body Composition, and Metabolic Syndrome in Adults.
    Ngu YJ; Skalny AV; Tinkov AA; Tsai CS; Chang CC; Chuang YK; Nikolenko VN; Zotkin DA; Chiu CF; Chang JS · Biological trace element research · 2022
    Cross-sectional study150 participantsWeight Loss forChromium
  19. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Jamilian M; Asemi Z · Annals of nutrition & metabolism · 2016
    Randomized trial64 participantsMetabolism Boost forChromium
  20. A Comprehensive insight into the effect of chromium supplementation on oxidative stress indices in diabetes mellitus: A systematic review.
    Kooshki F; Tutunchi H; Vajdi M; Karimi A; Niazkar HR; Shoorei H; Pourghassem Gargari B · Clinical and experimental pharmacology & physiology · 2024
    Systematic review33 studies pooledMetabolism Boost forChromium
  21. Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis.
    Zhu X; Wu C; Qiu S; Yuan X; Li L · Nutrition & metabolism · 2022
    Meta-analysis283 participants9 studies pooledMetabolism Boost forResveratrol
  22. Effects of resveratrol supplementation on multiple health outcomes: an umbrella review of systematic reviews and meta-analyses of randomized controlled trials.
    Sun JN; Yang R; Fang L; Li YJ; Xing WY; Sun ML; Wu L; Wu QJ; Gong TT · Nutrition journal · 2026
    Meta-analysis45 studies pooledMetabolism Boost forResveratrol
  23. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M · Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2015
    Randomized trial60 participantsMetabolism Boost forResveratrol
  24. Supplementation with resveratrol modified gut microbiota improving insulin sensitivity and lipid metabolism in subjects with obesity and insulin resistance.
    Guevara-Cruz M; Sánchez-Tapia M; Velazquez-Villegas LA; Torre-Villalvazo I; Guizar-Heredia R; Godínez-Salas E; López-Barradas A; Granados O; Torres-Villalobos G; Torres N; Tovar AR · European journal of nutrition · 2026
    Randomized trial32 participantsMetabolism Boost forResveratrol
  25. Efficacy of Resveratrol Supplementation on Glucose and Lipid Metabolism: A Meta-Analysis and Systematic Review.
    Zhou Q; Wang Y; Han X; Fu S; Zhu C; Chen Q · Frontiers in physiology · 2022
    Meta-analysis1,171 participants25 studies pooledMetabolism Boost forResveratrol